Marc Pillemer is a Senior Managing Director at Blue Owl and member of the GP Strategic Capital Investment Team. In his role, Marc focuses on sourcing and underwriting minority equity investments and financing transactions and strategic initiatives across the GP Strategic Capital platform.

Before joining Blue Owl, Marc was a Managing Director at Blackstone where he had a senior role on the Investment Team of Blackstone's GP Stakes platform based in New York. In this role, his responsibilities included sourcing, negotiating, and executing transactions and managing relationships with partner GPs. Marc also led the GP Strategic Support Team, which provides strategic benefits to partner GPs. Prior to that, he was a Managing Director in the Financial Institutions Group within the Investment Banking Division at Goldman, Sachs & Co., advising alternative asset managers on M&A and capital raising transactions, and on strategic initiatives. Marc began his career serving in various roles in the Securities Division and the Investment Management Division at Goldman, Sachs & Co.

Marc received his BCom in Actuarial Studies and Finance from Macquarie University in Sydney, Australia.

Megan Pirooz is a Principal at Blue Owl and member of the Legal Team. In her role, she focuses on supporting Blue Owl's Digital Infrastructure strategy.

Before joining Blue Owl, Megan was Associate General Counsel at IPI Partners, predecessor to Blue Owl's Digital Infrastructure strategy. Prior to that, she was an associate with Winston & Strawn LLP providing legal advice to private equity sponsors, public companies and lenders.

Megan received her JD, cum laude, from the Michigan State University College of Law. She also holds an LLM in Law and Entrepreneurship from Duke Law School and a BA in Political Science, with honors, from the University of Michigan.

Tracy Poulter Hart is a Senior Managing Director at Blue Owl and the Chief Human Resources Officer. Before joining Blue Owl, Tracy was CHRO of York Capital Management, a multi-strategy hedge fund, from September 2011 to April 2021. Prior to that, she was an Executive Director in HR at UBS where she was an HR Business Partner covering Equity Sales and Trading, Equity Derivatives, IT, Operations and was Head of HR for Latin America. Tracy started her career in roles at JP Morgan and Prudential.

Tracy received her BA in Business Management from Western CT State University.

Matt Press is a Principal at Blue Owl and member of the Legal Team. In his role, he focuses on supporting the firm's interval funds and future regulated products from a legal and regulatory perspective.

Before joining Blue Owl, Matt was Counsel at Lord Abbett. Prior to that, he was an Associate at Clifford Chance.

Matt received his JD, cum laude, from Rutgers School of Law-Newark and holds a BA in Economics and International Relations from Lehigh University.

Kevin Purcell is a Senior Managing Director at Blue Owl and member of the GP Strategic Capital Investment Team. In his role, he focuses on GP Stakes Investing and strategic initiatives across the GP Strategic Capital platform.

Before joining Blue Owl, Kevin was a Vice President at Neuberger Berman Private Equity. Kevin began his career as an Associate in the Investment Management Division at Lehman Brothers focused on strategic projects throughout the hedge fund platform and minority stake acquisition program.

Kevin received his MBA from the Krannert School of Management at Purdue University and holds a BS in Finance from Siena College.

Ashley Putterman is a Managing Director at Blue Owl and member of the Credit Finance & Capital Markets Team. In her role, she is responsible for overseeing leverage strategy and execution for the firm’s Financial Assets business within Alternative Credit.

Before joining Blue Owl, Ashley was Head of Capital Markets for the Financial Assets business at Atalaya Capital Management, the predecessor firm to Blue Owl's Alternative Credit team. Prior to that, she was Head of Capital Markets at Fundbox, an embedded working capital platform for small businesses, and had previous capital markets roles at Kabbage and Spruce Finance. Ashley began her career as an Investment Banking Analyst at Miller Buckfire.

Ashley received a BS in Economics with a concentration in Finance from the Wharton School and a BSE in Systems Engineering, magna cum laude, as part of the Jerome Fisher Program in Management & Technology (M&T) at the University of Pennsylvania.

Priscilla Quek is a Principal at Blue Owl and member of the Institutional Business Development Team. In her role, she manages the firm's South East Asian LPs and focuses on institutional business development in South East Asia.

Before joining Blue Owl, Priscilla was an Assistant Vice President at GIC. Prior to that, she was a Senior Associate at General Atlantic and an Associate in Credit Suisse's Private Fund Group. She began her career as an Investment Analyst at Hamilton Lane.

Priscilla received her BS and BA in Statistics and International Studies (Honors), from the University of Michigan.

Daniela Quintanilla is a Principal at Blue Owl and member of the Institutional Business Development Team. In her role, she focuses on institutional client relationship management.  

Daniela joined Blue Owl from Kuvare Asset Management (KAM), predecessor to Blue Owl Insurance Solutions. She joined Kuvare in 2022 at the inception of the third-party client business. At KAM, she was a Director in Business Development and Product Strategy. Prior to that, she was a Vice President at BlackRock, where she led insurance client business development alongside marketing and regulatory efforts that helped propel the ETF business forward. 

Daniela holds a BA in Political Science and History from Columbia University and an MBA from Columbia Business School. Daniela is a CAIA charterholder and a member of the CAIA Association. 

Kevin Raidy is a Senior Managing Director at Blue Owl and the Head of Healthcare Opportunities. In this role, he oversees all private and public investment activity related to Healthcare Opportunities and sits on the Fund’s Investment Committee.

Previously Kevin was a founder and Managing Partner of Cowen Healthcare Investments, the predecessor to Blue Owl Healthcare Opportunities. Prior to his role at Cowen Healthcare Investments, Kevin was Cowen’s Head of Investment Banking and prior to that he was Co-Head of Cowen’s Equity Capital Markets Group. Before that Kevin was a Managing Director at Ramius LLC where he was responsible for direct investments and convertible bonds. Kevin’s sell side experience includes 10 years at Shipley Raidy Capital Partners, a boutique investment banking firm which he co-founded. Prior to founding Shipley Raidy, Kevin was an associate at Philadelphia First Group. He started his career at Cantor Fitzgerald before moving to Merrill Lynch as an analyst in the municipal finance group.

Kevin is a member of the Board of Directors of NodThera Ltd, Neuron23, Aro Biopharmaceuticals and Latigo Biotherapeutics, while also a Board Observer at Delfi Diagnostics and Aktis Oncology.

Kevin received a BS in Economics with a concentration in Finance from the Wharton School of the University of Pennsylvania.

Matthew Rees is a Senior Managing Director at Blue Owl and member of the GP Strategic Capital Investment Team. Based in London, he focuses on managing Blue Owl's GP Strategic Capital relationships with investors and alternative asset management firms in Europe, the Middle East, and Asia.

Before joining Blue Owl, Matthew was the Global Head of Marketing for the NB Alternatives platform, a group of hedge fund and private equity businesses.

Matthew received his degree in accounting and economics from The Pennsylvania State University and holds an MBA from New York University.